Left Ventricular (Lv) Geometry and Dipping State Are Determinants of Lv Mass Reduction with Angiotensin-converting Enzyme Inhibitor Antihypertensive Treatment.
From: 1st Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Kyparissias 14, Kato Acharmes, 13571 Athens, Greece. conazna@yahoo.com
Blood pressure monitoring
- Publish Date: Apr 2007
- ISSN: 1359-5237
- Volume: 12
- Issue: 2
- Pages: 87-94
- Medium: Print
- Language: English
- Citation (JAMA): Aznaouridis Konstantinos A, Vyssoulis Gregory P, Karpanou Eva A, et al. Left Ventricular (Lv) Geometry and Dipping State Are Determinants of Lv Mass Reduction with Angiotensin-converting Enzyme Inhibitor Antihypertensive Treatment.. Apr 2007;12:87-94
Abstract
OBJECTIVES: Left ventricular hypertrophy is a major risk predictor in hypertensive patients and its regression is beneficial in terms of prognosis. The aim of this observational, open-labeled study was to investigate the effect of left ventricular geometry and dipping pattern on left ventricular mass reduction after chronic treatment with angiotensin-converting enzyme inhibitors, in a large population of hypertensive patients. METHODS: We evaluated untreated patients with mild to moderate essential hypertension, before and 6 months after treatment with angiotensin-converting enzyme inhibitor monotherapy or angiotensin-converting enzyme inhibitor-low-dose thiazide combination. Left ventricular mass index, relative wall thickness and geometry pattern were derived from echocardiography. Dipping state was determined with 24-h ambulatory blood pressure monitoring at enrollment. RESULTS: Overall, left ventricular mass index decrease in the 1400 patients (mean age 52.5 years) who completed the study was 12.9% of baseline value (P<0.00001). After adjusting for pretreatment value, left ventricular mass index reduction was similar with all angiotensin-converting enzyme inhibitors used [P= NS (not significant)], but it was higher in nondippers than dippers (14.1 vs. 12.3%, P<0.0001) and in patients with than without baseline left ventricular hypertrophy (14.6 vs. 11.3%, P<0.0001). We observed a stepwise augmentation of left ventricular mass index decrease with worsening left ventricular geometry (P<0.001). In multivariable analysis, impaired left ventricular geometry and blunted nocturnal blood pressure fall before treatment were independent predictors of a high left ventricular mass index reduction after treatment, independent of blood pressure fall, pretreatment left ventricular mass index, and other potential confounders. CONCLUSION: In essential hypertension, left ventricular geometry and dipping state are independent determinants of left ventricular mass reduction with angiotensin-converting enzyme inhibitor treatment. All angiotensin-converting enzyme inhibitors are efficient in decreasing left ventricular mass.
Mesh Headings (Keywords): Adult, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Drug Therapy, Combination, Female, Humans, Hypertension, Hypertrophy, Left Ventricular, Male, Middle Aged, Multivariate Analysis, Prognosis, Regression Analysis, Risk Factors, Sodium Chloride Symporter Inhibitors
Check for Full Text / PubMed Unique Identifier (PMID): 17353651
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.